IL1B and rheumatoid arthritis: In humans, excessive IL-1β secretion is known to cause disease and several therapeutic strategies are available to target IL-1β in inflammatory conditions such as rheumatoid arthritis, including the IL-1β receptor antagonist (IL-1ra) anakinra [4].